34 - Dose Range Finding Studies (S3E4)

All right, so we're diving into dose range finding
studies today. You had some questions about this.
How do scientists actually figure out the right
dose for a new drug, especially when they're
using animal models? Yeah, it's a pretty complex
process. I bet. There's a lot that goes into
it. It's not just about finding a dose that works.
It's about finding that sweet spot where it's
effective, but it's also safe. Right, you gotta
avoid that toxic zone, right? Exactly. And there
are all sorts of regulations and guidelines,
too. It's a really fascinating area. Okay, so
let's back up for a second. Why are animal models
so important in this process? I mean, before
we even think about testing on humans... Why
do we need to go through this step with animals?
Well, you wouldn't want to test a brand new drug
on a person without having any idea how it would
behave in a living system. That makes sense.
Too risky. Way too risky. So animal models give
us a way to study the drug in a controlled environment.
It's a way to gather data on its safety and effectiveness
before we even think about moving to human trials.
Makes sense. So how does that actually work?
I mean, where do they even start? Well, one of
the most basic techniques is what we call an
intravenous bolus. Intravenous bolus. Yeah, it
sounds a little intimidating, but it's basically
just a way to get the drug into the system quickly.
You inject it right into the bloodstream. Ah,
so it bypasses all the stuff that happens when
you take a pill, for example. Exactly. And that
lets us observe the drug's behavior almost immediately.
We can see how it starts to work, how it distributes
throughout the body. So it's kind of like treating
the body as a single compartment. Yeah, it's
a simplification of course, but it gives us a
good starting point. And to understand how a
drug really behaves, we need to look at something
called pharmacokinetic parameters. Pharmacokinetic
parameters. Yeah. Think of these as our detectives
for drug behavior. OK. They tell us how the drug
is absorbed, distributed, metabolized, and then
eliminated from the bottle. Our little drug detectives.
Oh. OK. So tell me more about these detectives.
What kind of clues are they looking for? All
right. So one of the key players here is the
apparent volume of distribution. it's often represented
by the letter V. V for volume, right? Yeah, but
it's not a volume you can actually measure, like
with a ruler or something. It's more of a mathematical
tool. Okay, so it's not like a literal. No, it's
more about understanding where the drug goes
in the body, like how much of it stays in the
bloodstream and how much of it goes into the
tissues. Got it. Think of it this way. Imagine
you have a beaker of water with charcoal in it.
OK. If you add some kind of substance to that
water, some of it will bind to that charcoal.
Right. And that changes the overall concentration
of the substance in the water. Makes sense. So
it's kind of like that. Yeah. The V value helps
us understand how much of a drug binds to tissues,
which tells us how it's distributed throughout
the body. OK. That's a good analogy. So a high
V would mean the drug is spreading out a lot.
Exactly. And a low V would mean it's mostly staying
in the blood. All right. Got it. So what other
detective clues are we looking for? Well, there's
also the elimination half -life, or T. This one's
all about time. Time. Yeah. It tells us how long
it takes for half of the drug to be eliminated
from the body. Oh, OK. So that would affect how
often you need to take it, right? Like, if it
gets eliminated quickly, you need to take it
more often. Exactly. And that's why T is so important
in determining the right dosing schedule. And
then we have the elimination rate. Constant,
or K. K. Yeah, think of this one as the speed
at which the drug exits the body. OK, so high
K, it's leaving quickly. Exactly. And those usually
go hand -in -hand with a shorter half -life.
Right. It all makes sense. They're all connected.
So we've got our detectives. We've got our clues.
But how do they actually figure out the right
dose range? How do they put all of this together?
Well, that's where things get really interesting.
They track the drug's concentration in the blood
over time, and they use those pharmacokinetic
parameters, like V, T, and K, to build a mathematical
model. A model? Yeah, it's like a simulation
of how the drug is behaving in the body. And
that model helps them predict what will happen
at different doses. They can use it to calculate
an initial safe dose range. So they're not just
guessing. They're actually building a model to
figure this out. Exactly. And of course, there
are tons of regulations and guidelines to make
sure all of this is done ethically and consistently.
The FDA and the ICH, they're all over this. That
makes sense, right? Huge responsibility. So it's
not just about the science. It's about Protecting
the animals and ultimately the humans, too. Absolutely.
It's about laying a solid foundation for drug
development where safety and effectiveness are
the top priorities. This is fascinating. But
I'm curious, how do they figure out the actual
dosing schedule? Do they give it all at once?
Spread it out? How does that work? That's a great
question, and it's where things get even more
interesting. The dosing schedule can make a big
difference in how well a drug works and how safe
it is. Maybe we can dive into those different
approaches after a quick break. Yeah, let's do
that. We'll be right back to explore all those
different dosing strategies. So we talked about
how those pharmacokinetic detectives like V,
T, and K help us figure out that starting dose
range. But the dosing schedule, that's another
big piece of the puzzle. Yeah, I was thinking
about that. Like, giving a drug once a day versus,
I don't know, multiple times a day, that seems
like it would make a huge difference. Oh, absolutely.
The timing and frequency of those doses can really
impact how the drug behaves in the body. Think
about it like cooking, right? Sometimes you throw
everything in the pot at once, and sometimes
you have to add ingredients slowly. I like that
analogy. So walk me through some of the different
dosing schedules they might try in these studies.
Well, one approach is what's called a single
dose study. They give the animal just one dose
and then carefully monitor what happens. It's
like taking a snapshot of the drug's behavior
at that specific time. OK, that makes sense for
getting an initial understanding. But what about
long term effects? How do they study that? For
that, they might use a repeated dose study. So
giving the drug multiple times over days, weeks,
maybe even months. So like a time lapse video
instead of a single picture. Exactly. And that
helps them understand how the drug builds up
in the body over time. They can see if there
are any cumulative effects or any signs of toxicity.
So it's not just about the dose itself. It's
about how often you give it, too. Right. And
within those repeated dose studies, there are
different variations, like giving the drug once
a day, twice a day, or even more often. It all
depends on the drug's half life and what kind
of effect they're looking for. Makes sense. A
short half -life, you need to give it more frequently
to keep it working. Exactly. It's like tailoring
a suit. You need the right measurements for it
to fit properly. And it's not just about how
often, but also the route of administration.
We've talked about intravenous bolus, but you
can give drugs orally, intramuscularly, subcutaneously,
even through inhalation. Wow. So many options.
It seems like there are a lot of factors to consider.
But how do they actually measure the outcomes?
What are they looking for to know if the drug
is safe and effective? Well, they use a whole
range of outcome measures for both efficacy and
toxicity. On the efficacy side, they might look
for changes in biomarkers or improvement in behavioral
tests. If it's a cancer drug, they might measure
tumor size. So it's tailored to what they're
trying to treat. Exactly. And for toxicity, they're
looking for any signs of adverse effects like
changes in blood chemistry or even organ damage.
It's a delicate balancing act, isn't it? Trying
to get the good effects without causing any harm.
That's exactly it. And that's why these preclinical
studies are so important. They're the foundation
for those clinical trials in humans. Now, I remember
you mentioned earlier that intravenous bolus
is kind of like a starting point. because it
bypasses the complexities of absorption. But
how do they factor in different routes of administration
when they're figuring out the dose and schedule?
I mean, a pill is going to be different from
an injection, right? That's a great point. It's
true that IV is the most direct route, but often
a drug will be given orally or some other way.
So they do have to account for those differences.
So how do they do that? How do they adjust for
the fact that, say, a pill might not be absorbed
as well as an injection? Well, there's this concept
called bioavailability. It basically refers to
how much of the drug actually gets into the bloodstream.
With 5e, it's pretty much 100 % because you're
putting it directly into the bloodstream. But
with a pill, some of it might get broken down
before it even gets there. Exactly. And that
can vary depending on things like the drug's
formulation, whether it's taken with food and
even individual differences in metabolism. So
if a drug isn't absorbed well when taken orally,
they might need to give a higher dose to get
the same effect. That's right. And this is where
those pharmacokinetic parameters come back into
play. They help us predict how the drug will
behave based on the route of administration.
Wow, this is really complex. I'm starting to
see how all these pieces fit together. Like,
you have to think about the route, the bioavailability,
the half -life, the volume of distribution. It's
a lot. It is. It's like fine -tuning an instrument.
And researchers use all sorts of tools, mathematical
models, lab techniques, to figure out how to
dose a drug effectively. This has been so insightful.
We've talked about animal models, dosing schedules,
outcome measures. It's amazing how much goes
into this research. But I'm curious, are there
any limitations, any challenges they face in
these studies? That's a great question, and it
speaks to how this field is always evolving.
Maybe we can explore some of those challenges
after a quick break. We'll be right back. Sounds
good. We'll be back in a moment to continue our
deep dive into the world of dose range finding
studies. So you asked about challenges in these
dose range finding studies. Well, one of the
biggest is, you know, animal models and humans,
they're not exactly the same. Right, a mouse
isn't a tiny human. Yeah, exactly. What works
in a mouse might not work the same way in a human.
Of course. There can be differences in how the
drug is absorbed, how it's broken down, even
how it's eliminated from the body. And then even
within a species, you have variations like age,
sex, genetics, all those things can play a role.
So you can't just assume that what you see in
an animal study will perfectly translate to humans.
Exactly. It's like, oh, well, it's not a perfect
one -to -one comparison. And that's why those
regulations we talked about, those are so crucial.
Having standardized methods, rigorous controls,
all of that helps minimize those variations and
makes the data more reliable. So it's about controlling
what you can control. Are there other limitations
they have to think about? Oh, absolutely. There's
the ethical aspect of using animals in research.
You know, animal research is essential for medical
progress, but it has to be done ethically. We
have a responsibility to those animals. Yeah,
it's a tough balance, isn't it? The need for
this research versus the well -being of the animals.
Exactly. And that's why there's this big push
for what we call the three Rs. Replacement, reduction,
and refinement. The three Rs. Tell me more about
those so replacement means finding alternatives
to using animals whenever possible like cell
cultures or computer models and Reduction means
using the fewest animals possible while still
getting good data and then refinement That's
all about improving the experiments themselves
to reduce any pain or distress for the animals
So it's about constantly finding ways to do things
better more humanely Exactly. And those ethical
considerations, they're part of every step from
choosing the right animal model to how the experiments
are designed to making sure the animals are well
cared for. That's good to hear. You mentioned
that this field is always evolving. So are there
any new technologies or approaches that might
change how they do these studies in the future?
Oh yeah, definitely. One really exciting area
is these in vitro models that are becoming more
and more human relevant. They use human cells
or tissues grown in the lab, so you're getting
closer to studying the drugs effects in a human
system. Bringing the human element into the lab.
Exactly. And then there's computer modeling.
That's becoming a big deal. Researchers can create
virtual models of the body and test how different
drugs might behave, potentially reducing the
need for some animal studies. Wow, so technology
is opening up a whole new world for this kind
of research. It really is. And as those technologies
keep advancing, we're going to see even more
precise and efficient ways to figure out the
right dose for new drugs. This has been incredibly
insightful. We've covered so much ground from
those little drug detective parameters to the
complexities of dosing schedules and outcome
measures, and of course, the ethical side of
things, which is so important. What do you think
is the most important thing for people to take
away from this conversation? I'd say it's that
balance, that constant balancing act between
wanting the drug to work, but also wanting it
to be safe. It's like walking a tightrope, trying
to find that sweet spot where the benefits outweigh
the risks. And honestly, it's really amazing
what these researchers are doing, you know, pushing
the boundaries of science to find new treatments
while also being mindful of the ethical implications.
It really is remarkable work. I think we've all
learned a lot about the science behind the challenges,
and the ethical considerations that are so important.
As you continue to think about all of this, maybe
consider this, how do you think personalized
medicine, you know, tailoring treatments to individuals,
how might that impact the future of dose range
finding studies? That's something to think about.
Oh, that's a great point. Yeah, that idea of
personalized medicine, that could really shake
things up. It shows just how dynamic this field
is. You know, the quest to find safe and effective
treatments, it's an ongoing journey, but with
all these advancements, I think the future of
drug development is incredibly bright. Well,
thanks for joining us on this deep dive into
dose range finding studies. Until next time,
keep asking those questions and keep exploring.